|
Variables
|
All cases
|
Survivors
|
Non-survivors
|
P
value
|
|---|
|
(
N
= 337)
|
(
N
= 174)
|
(
N
= 163)
|
|---|
|
Pathogens
| | | | |
|
Single microbial
|
180 (53.4)
|
98 (56.3)
|
82 (50.3)
|
0.269
|
|
Polymicrobial
|
157 (46.6)
|
76 (43.7)
|
81 (49.7)
|
|
P. aeruginosa
|
76 (22.2)
|
32 (18.5)
|
44 (27.0)
|
0.063
|
|
MRSA
|
49 (14.5)
|
18 (10.3)
|
31 (19.0)
|
0.024
|
|
K. pneumoniae
|
19 (5.6)
|
9 (5.2)
|
10 (6.1)
|
0.702
|
|
Othersa
|
29 (8.6)
|
19 (10.9)
|
10 (6.1)
|
0.118
|
|
Groups of A. baumannii
| | | | |
|
DS
|
33 (9.8)
|
26 (14.9)
|
7 (4.3)
|
<0.001
|
|
MDR
|
72 (21.4)
|
49 (28.2)
|
23 (14.1)
|
|
XDR
|
220 (65.3)
|
95 (54.6)
|
125 (76.7)
|
|
PDR
|
12 (3.6)
|
4 (2.3)
|
8 (4.9)
|
|
Antibiotic treatment
| | | |
0.110
|
|
Single antibiotic
|
120 (36.0)
|
69 (40.4)
|
51 (31.5)
|
|
Combined antibiotics
|
213 (64.0)
|
102 (59.6)
|
111 (68.5)
|
|
Time to start antibiotic
| | | |
0.125
|
|
Early (within 24 h)
|
307 (91.1)
|
163 (93.7)
|
144 (88.3)
| |
|
Late (>24 h)
|
30 (8.9)
|
11 (6.3)
|
19 (11.7)
|
|
Empirical antibiotic treatment
| | | |
<0.001
|
|
Appropriate
|
212 (62.9)
|
133 (76.4)
|
79 (48.5)
|
|
Inappropriate
|
125 (37.1)
|
41 (23.6)
|
84 (51.5)
|
-
DS drug-sensitive, MDR multidrug-resistant, XDR extensively drug-resistant, PDR pandrug-resistant A. baumannii, MRSA methicillin-resistant Staphylococcus aureus.
-
aOthers including E. coli, S. maltophilia, H. influenzae, methicillin-sensitive Staphylococcus aureus, and Enterococcus spp.
